These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25515952)

  • 21. Assessing Radiographic Response to
    Anand A; Trägårdh E; Edenbrandt L; Beckman L; Svensson JH; Thellenberg C; Widmark A; Kindblom J; Ullén A; Bjartell A
    J Nucl Med; 2020 May; 61(5):671-675. PubMed ID: 31586004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ; Li TY; Yang XC; Jia N; Yang XL; Song HB
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen flare induced by
    Castello A; Macapinlac HA; Lopci E; Santos EB
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2256-2263. PubMed ID: 29785515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
    Küronya Z; Sinkovics I; Ágoston P; Bíró K; Bodrogi I; Böde I; Dank M; Gyergyay F; Vajdics T; Kolonics Z; Nagyiványi K; Rúzsa Á; Géczi L
    Pathol Oncol Res; 2017 Oct; 23(4):777-783. PubMed ID: 28074331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of Palliative
    Arays R; Ahmad Z; Howard L; Veselicky K; Kolodney J; SijinWen ; Hogan T
    J Nucl Med Technol; 2021 Mar; 49(1):70-74. PubMed ID: 33219158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response.
    Roque V; Jessop M; Pereira L; Gape P; Dizdarevic S; Sousa E; Carolino E
    Nucl Med Commun; 2019 Jun; 40(6):588-596. PubMed ID: 30908340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone-targeted treatment in prostate cancer].
    Géczi L; Sinkovics I
    Magy Onkol; 2014 Sep; 58(3):199-203. PubMed ID: 25260084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment PSA levels affects the completion rate of Ra-223 treatment.
    Utsumi N; Kurosaki H; Miura K; Kitoh H; Akakura K
    Sci Rep; 2021 Mar; 11(1):6476. PubMed ID: 33742050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-Specific Antigen Flare Phenomenon During
    De Vincentis G; Follacchio GA; Frantellizzi V; Liberatore M; Monteleone F; Cortesi E
    Clin Genitourin Cancer; 2016 Oct; 14(5):e529-e533. PubMed ID: 27212044
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
    Taue R; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radium-223 for men with hormone-refractory prostate cancer and bone metastases.
    Shelley MD; Mason MD
    Lancet Oncol; 2007 Jul; 8(7):564-5. PubMed ID: 17613416
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival outcomes of radium-223 therapy for metastatic castration-resistant prostate cancer following national health insurance reimbursement in Taiwan.
    Yao SF; Huang WJ; Wei TC; Wang YF; Lin KH; Hu LH; Ting CH; Lee TH; Yeh SH; Peng NJ
    J Chin Med Assoc; 2024 Jul; 87(7):734-740. PubMed ID: 38771079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study.
    Yang HC; Chang LW; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Chen CC; Wang SC; Lin CY; Cheng CL; Ou YC; Chiu KY; Hung SC
    Anticancer Res; 2023 Apr; 43(4):1809-1816. PubMed ID: 36974814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223.
    Naito M; Ukai R; Hashimoto K
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1203. PubMed ID: 32721117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.
    Ahmadzadehfar H; Schlenkhoff CD; Rogenhofer S; Yordanova A; Essler M
    Clin Nucl Med; 2016 Sep; 41(9):695-6. PubMed ID: 27405025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker.
    Heinrich D; Bruland Ø; Guise TA; Suzuki H; Sartor O
    Future Oncol; 2018 Oct; 14(24):2543-2556. PubMed ID: 29925281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report.
    McNamara MA; George DJ
    BMC Cancer; 2015 May; 15():371. PubMed ID: 25948240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radium-223 treatment of bone metastases from castration-resistant prostate cancer].
    Mortensen J; Højgaard L
    Ugeskr Laeger; 2014 Jul; 176(30):1399-402. PubMed ID: 25292232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.